CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-03 | Ondrey Aaron Chief Financial Officer | Sale | −1,477 | $2.88 | $4K | 128,173 |
| 2025-04-04 | Ondrey Aaron Chief Financial Officer | Sale | −7,489 | $5.29 | $40K | 129,650 |
| 2025-02-11 | Ondrey Aaron Chief Financial Officer | Grant or award | +90,358 | 137,139 | ||
| 2025-02-11 | Ondrey Aaron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +134,642 | 134,642 | ||
| 2024-04-01 | Ondrey Aaron Chief Financial Officer | Grant or award | +46,781 | 46,781 | ||
| 2024-04-01 | Ondrey Aaron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +69,337 | 69,337 |
Page 1 of 1 · 6 trades